Chelsea Clinton Steps Down from Clover Health Board After 8-Year Tenure
Chelsea Clinton, a long-serving member of Clover Health's Board, will step down on October 31, 2025. During her tenure, she played a crucial role in the company's growth and transformation.
Chelsea Clinton joined Clover Health's Board in early 2017 and has been its longest-serving member. She served on the Talent & Compensation Committee and the Nominating and Corporate Governance Committee. In her over eight years of service, Clinton guided the company's expansion from a privately held entity serving 30,000 members to a publicly traded organization serving over 100,000 seniors across multiple states.
Chelsea Clinton's leadership and impact were praised by Clover Health's Executive Chairperson Vivek Garipalli and CEO Andrew Toy. Garipalli thanked her for her partnership and enduring support, while Toy expressed gratitude for her leadership and her influence on the company's mission. Clover Health's strategy, powered by its software platform Clover Assistant, aims to improve health outcomes by aggregating patient data to support clinical decision-making. The company remains committed to maintaining a strong, diverse, and experienced Board to guide its ongoing growth and mission.
Chelsea Clinton's departure from Clover Health's Board in late 2025 will mark the end of her pivotal role in the company's growth and success. Despite her departure, Clover Health remains dedicated to its mission of bringing access to great healthcare to everyone on Medicare, with a focus on seniors who have historically lacked access to affordable, high-quality health insurance.
